Sulfonylureas and the risk of myocardial infarction

Metabolism: Clinical and Experimental
Henriette ThistedJørgen Rungby

Abstract

Patients with diabetes mellitus have an increased risk of coronary artery diseases such as myocardial infarction. Sulfonylureas are used in the treatment of diabetes mellitus and have been linked with adverse cardiovascular effects due to an apparent effect on myocardial ischemic preconditioning. Individual sulfonylureas differ pharmacologically and may have different effects. Although the hypotheses were stimulated by animal studies and experimental studies using intermediate end points, data on the possible clinical implications in humans remain sparse. However, recent data seem reassuring.

References

Oct 1, 1988·Diabetic Medicine : a Journal of the British Diabetic Association·H Beck-NielsenO Pedersen
Aug 1, 1985·Diabetes·G UlvenstamC Wilhelmsson
Sep 1, 1996·Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Métabolisme·K GeisenJ G Papp
May 22, 2002·JAMA : the Journal of the American Medical Association·Joshua A BeckmanPeter Libby
Feb 8, 2003·The Journal of Clinical Endocrinology and Metabolism·Tsung-Ming Lee, Tsai-Fwu Chou
Jun 24, 2003·Diabetologia·F M Gribble, F Reimann
May 27, 2004·Cardiovascular Drugs and Therapy·Helen L MaddockDerek M Yellon
Apr 29, 2006·American Journal of Therapeutics·S P JohnsenJ Rungby

❮ Previous
Next ❯

Citations

Oct 2, 2009·Current Diabetes Reports·Edoardo Mannucci, Matteo Monami
Jul 4, 2012·Cardiovascular Diabetology·Lisa KitasatoMinako Yamaoka-Tojo
Feb 25, 2014·Current Diabetes Reports·Peter M Thulé, Guillermo Umpierrez
Mar 13, 2010·Expert Review of Cardiovascular Therapy·Christina L Aquilante
May 25, 2011·Expert Opinion on Drug Safety·Devindra SehraShiv Tej Sehra
Oct 19, 2006·Expert Opinion on Drug Safety·Andrew J Krentz
Mar 31, 2009·International Journal of Cardiology·Edoardo MannucciNiccolò Marchionni
Mar 27, 2007·Diabetes/metabolism Research and Reviews·M MonamiE Mannucci
Apr 19, 2013·Diabetes, Obesity & Metabolism·M MonamiE Mannucci
Mar 20, 2014·British Journal of Pharmacology·D Kaiser, E Oetjen
Dec 26, 2007·Current Medical Research and Opinion·S M BeardR A Malik
Dec 25, 2007·Current Medical Research and Opinion·Andrew J Krentz
Dec 4, 2014·The Lancet. Diabetes & Endocrinology·Scot H SimpsonTravis R Featherstone
Dec 3, 2014·The Medical Clinics of North America·Stephen A Brietzke
Mar 29, 2008·Clinical Journal of the American Society of Nephrology : CJASN·Eberhard Ritz, Christoph Wanner
Aug 13, 2010·The Journal of Clinical Endocrinology and Metabolism·Marianne ZellerUNKNOWN French Registry of Acute ST-Elevation and Non-ST-Elevation Myocardial Infarction investigators
Jul 11, 2020·European Journal of Pharmacology·Moumita NathYashmin Choudhury
Oct 18, 2007·Current Opinion in Endocrinology, Diabetes, and Obesity

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiovascular Inflammation

Inflammation plays a significant role in the development of cardiovascular diseases, an understanding of these endogenous processes is critical for evaluating the risks and potential treatment strategies. Discover the latest research on cardiovascular inflammation here.

CV Disorders & Type 2 Diabetes

This feed focuses on the association of cardiovascular diseases in patients with type 2 diabetes.